Capital Planning Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,109
| Closed | -$587K | – | 125 |
|
|
2022
Q3 | $587K | Sell |
7,109
-10,842
| -60% | -$895K | 0.16% | 75 |
|
|
2022
Q2 | $1.71M | Buy |
17,951
+332
| +2% | +$31.6K | 0.45% | 51 |
|
|
2022
Q1 | $2.07M | Buy |
17,619
+244
| +1% | +$28.7K | 0.44% | 57 |
|
|
2021
Q4 | $2.25M | Sell |
17,375
-121
| -0.7% | -$15.7K | 0.43% | 60 |
|
|
2021
Q3 | $1.98M | Sell |
17,496
-161
| -0.9% | -$18.2K | 0.41% | 62 |
|
|
2021
Q2 | $1.83M | Sell |
17,657
-54
| -0.3% | -$5.59K | 0.38% | 69 |
|
|
2021
Q1 | $1.48M | Buy |
17,711
+7,853
| +80% | +$657K | 0.33% | 71 |
|
|
2020
Q4 | $899K | Buy |
9,858
+141
| +1% | +$12.9K | 0.22% | 77 |
|
|
2020
Q3 | $776K | Buy |
9,717
+1,337
| +16% | +$107K | 0.21% | 81 |
|
|
2020
Q2 | $579K | Buy |
+8,380
| New | +$579K | 0.17% | 83 |
|